Eprex international pharmacoeconomical researches review
Anaemia of chronic kidney disease (CKD) is one of the most frequent complications which greatly accelerates the progression of main disease and makes for earlier renal replacement therapy. At this stage the costs of patient treatment grow appreciably. Timely intervention to correct anemia of CKD has impact on reduction of treatment expenditure, delaying progression to dialysis and quality of life improvement.